Cargando…
Newborn screening for Fabry disease in the north-west of Spain
Fabry disease is an X-linked lysosomal storage disorder caused by the impairment of α-galactosidase A. Enzyme replacement therapy is available to treat patients, who often experience delayed diagnosis. A newborn screening for Fabry disease was performed to study the prevalence of the pathology and t...
Autores principales: | Colon, Cristobal, Ortolano, Saida, Melcon-Crespo, Cristina, Alvarez, Jose V., Lopez-Suarez, Olalla E., Couce, Maria L., Fernández-Lorenzo, José R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511307/ https://www.ncbi.nlm.nih.gov/pubmed/28646478 http://dx.doi.org/10.1007/s00431-017-2950-8 |
Ejemplares similares
-
Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse
por: Cortés-Saladelafont, Elisenda, et al.
Publicado: (2023) -
Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family
por: San Millán-Tejado, Beatriz, et al.
Publicado: (2023) -
Fabry disease in the Spanish population: observational study with detection of 77 patients
por: Vieitez, Irene, et al.
Publicado: (2018) -
Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Newborn Screening for Fabry Disease: Current Status of Knowledge
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)